eLaws
|
eCases
|
United States Code
|
Federal Courts
|
Sign In
Sign Up
eLaws
eCases »
United States Code
Federal Courts »
Home
»
Rulemaking
» Draft Guidance for Industry on Self-Selection Studies for Nonprescription Drug Products; Availability
Draft Guidance for Industry on Self-Selection Studies for Nonprescription Drug Products; Availability
Document ID:
FDA-2011-D-0620-0001
Document Type:
Notice
Agency:
Food And Drug Administration
Topics:
No Topics associated with this document
Federal Register Number:
2011-23927
View Document:
Details Information
Document Subtype:
Notice of Availability
Received Date:
September 19 2011, at 12:00 AM Eastern Daylight Time
Start-End Page:
58018 - 58018
Page Count:
1
Comment Start Date:
September 19 2011, at 12:00 AM Eastern Standard Time
Comment Due Date:
November 18 2011, at 11:59 PM Eastern Standard Time
Comments
Total:
4
GlaxoSmithKline Consumer Healthcare - Comment
Posted:
12/22/2011
ID:
FDA-2011-D-0620-0007
Comment Period Closed
Nov 18,2011 11:59 PM ET
Consumer Healthcare Products Association (CHPA) - Comment
Posted:
12/22/2011
ID:
FDA-2011-D-0620-0004
Comment Period Closed
Nov 18,2011 11:59 PM ET
Eric Paul Brass - Comment
Posted:
11/14/2011
ID:
FDA-2011-D-0620-0003
Comment Period Closed
Nov 18,2011 11:59 PM ET
Merck Research Laboratories - Comment
Posted:
12/22/2011
ID:
FDA-2011-D-0620-0006
Comment Period Closed
Nov 18,2011 11:59 PM ET
Related Documents
Total:
0
No documents available.
Draft Guidance for Industry on Self-Selection Studies for Nonprescription Drug Products; Availability
Details Information
Comments
Posted: 12/22/2011 ID: FDA-2011-D-0620-0007
Nov 18,2011 11:59 PM ET
Posted: 12/22/2011 ID: FDA-2011-D-0620-0004
Nov 18,2011 11:59 PM ET
Posted: 11/14/2011 ID: FDA-2011-D-0620-0003
Nov 18,2011 11:59 PM ET
Posted: 12/22/2011 ID: FDA-2011-D-0620-0006
Nov 18,2011 11:59 PM ET
Related Documents